About

Primary Care Obesity Training is run by Dr Rachel Pryke, MBBS MRCGP FRCP, who is an experienced GP, trainer and obesity specialist from the West Midlands. She graduated from Kings College Hospital London in 1989, and completed the Certificate of Medical Education, Staffordshire University, in 2007. She was Clinical Champion for Nutrition for Health at the Royal College of General Practitioners between 2012-2015 and continues her involvement with an array of obesity and nutrition-related projects. This includes being a National Child Measuring Programme board member and member of PHE’s Obesity Priority Programme Board, in addition to holding a current NICE Fellowship.

Dr Pryke was GP representative on the RCP Obesity Working Party, and co-authored the primary care chapter of Action on obesity Comprehensive care for all, 2013. She was also a  member of the Academy of Medical Royal Colleges Obesity Steering Group, contributing to the 2013 publication of   Measuring Up: The medical profession’s prescription to the obesity crisis.

Dr Pryke sat on the 2012 Managing Adult Malnutrition in the Community pathway Consensus Panel    http://www.malnutritionpathway.co.uk

Author of two books, Weight Matters for Children https://books.google.co.uk/books?id=SoZ52Ha6fXoC&pg=PA218&lpg=PA218&dq=weight+matters+for+children&source=bl&ots=HS7OpOU0_M&sig=AtGOEIXeSbrtFGsKbXKzmfYSq0c&hl=en&sa=X&ved=0ahUKEwiAxrOcmM3MAhWHL8AKHbkRAakQ6AEIVDAJ#v=onepage&q=weight%20matters%20for%20children&f=false  (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082916/)  and Weight Matters for Young People, Radcliffe Publishing, Dr Pryke has developed extensive obesity training resources for primary care staff and is currently working with WHO Europe, having developed an international primary care obesity training package .

Other current projects include development of a child obesity intervention to be delivered by pharmacists, and ongoing input into the Lancet Commission on Liver Disease.

Declaration of Interests

Having been aware of increasing concerns about potential conflicts of interests for doctors with pharmaceutical industry I am very happy to make clear where my funding is from.

My main income is from NHS via my GP partnership at Winyates Health Centre. We have no private patients but some work is non-NHS on behalf of NHS patients.

I have done consultancy work for Nutricia in relation to developing the Managing Malnutrition in the Community guideline in 2014, and had speaker fees and expenses for talking about adult malnutrition at several conferences.

Nutricia funded the RCGP to support the Clinical Priority programme on Nutrition for Health, which I led between 2014 -2016. This money was used for expenses, supporting GPING meetings and for educational resource development. In 2018 they funded RCGP to support the Multimorbidity Spotlight programme which I lead. I claim expenses through RCGP in relation to this programme. Some of the funding supports ongoing GPING work and the office support provided by the RCGP.

In 2017 and 2018 I received £150 speaker fee from RCGP on 3 occasions, talking about infant growth and development of normal eating behaviours at a Cows milk allergy training day, run by RCGP but funded by Nutricia. I have now made the decision not to continue any involvement in this event due to my increasing reservations about how parental anxieties around baby feeding might potentially be exploited to promote baby milks. At no point have I promoted any baby formula milk.

In 2017 I had travel expenses from Novo Nordisk to attend a 2 day obesity educational forum. In 2018 Novo Nordisk funded the GPING/World Obesity Federation stand at the RCGP Glasgow conference and speaker fees for the lunchtime symposium on multimorbidity. Novo Nordisk also funded RCGP to put on the “Tacking chronic diseases through lifestyle behaviour changes, nutrition and physical activity” course held in Birmingham in June 2018.

I was paid by Medtronic to speak about obesity at a lunchtime symposium in Athens in May 2018.

The funding from these organisations has been unrestricted, with no influence over any of the educational materials I have written or delivered.  I have not engaged in any product promotion or industry-funded research. I strongly believe in evidence-based medicine.